Legault Pierre
SEC-identified person · CIK 1391045 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Syndax Pharmaceuticals Inc SNDX | Director | filed 2017–2026 |
| Bicycle Therapeutics plc BCYC | Director | filed 2019–2025 |
| Urovant Sciences Ltd. UROV | Director | filed 2018–2021 |
| Hepalife Technologies INC [ALQA] | Director | filed 2019–2019 |
| Armo Biosciences, Inc. ARMO | Director | filed 2018–2018 |
| Tobira Therapeutics, Inc. TBRA | Director | filed 2013–2016 |
| Nephrogenex, Inc. NRX | Director · Chief Executive Officer | filed 2014–2015 |
| NPS Pharmaceuticals INC NSPS | Director | filed 2014–2015 |
| Forest Laboratories, LLC frx | Director | filed 2012–2014 |
| OSI Pharmaceuticals INC OSIP | Exec. VP, CFO & Treasurer | filed 2009–2010 |
| Rite AID Corp RAd | Sr EVP & CAO | filed 2007–2008 |
| Xcyte Therapies INC XYCT | Director | filed 2007–2008 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.